A Phase 3b Study to Evaluate the Safety, One-year Antibody Persistence, and Priming Immune Responses of Three Doses of Eupolio Inj., a New Inactivated Polio Vaccine Made from Sabin Strains, and Immunogenicity of Two Doses of Eupolio Inj. Following Three Doses of bOPV in Infants.

María Rosario Capeding; Edison R. Alberto; Krongporn Ongprasert; Delia Yu; Maria Nerissa De Leon; Pope Kosalaraksa; Thanyawee Puthanakit; Boonyarat Warachit; Maria Esterlita V. Uy; Anna Lisa Ong‐Lim; Ilsu Kim; Jihyun Heo; Youngeun Roh; Keswadee Lapphra

doi:10.12688/verixiv.2667.1

A Phase 3b Study to Evaluate the Safety, One-year Antibody Persistence, and Priming Immune Responses of Three Doses of Eupolio Inj., a New Inactivated Polio Vaccine Made from Sabin Strains, and Immunogenicity of Two Doses of Eupolio Inj. Following Three Doses of bOPV in Infants.

2026 Preprint

View at publisher

Authors: María Rosario Capeding, Edison R. Alberto, Krongporn Ongprasert, Delia Yu, Maria Nerissa De Leon, Pope Kosalaraksa, Thanyawee Puthanakit, Boonyarat Warachit, Maria Esterlita V. Uy, Anna Lisa Ong‐Lim, Ilsu Kim, Jihyun Heo

+2 more

Youngeun Roh, Keswadee Lapphra

DOI: 10.12688/verixiv.2667.1

Cited by: 0

References: 20

Fields of Study & Subjects

Viral Infections and Immunology Research Vaccine Coverage and Hesitancy Virology and Viral Diseases

Publication details

Publication date: 19 January 2026
Document type: Preprint

References 20